Folashade Otegbeye

Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study

Srđan Verstovšek, Aaron T. Gerds, Alessandro M. Vannucchi et al. · The Lancet · 2023 · 164 citations

Hematological Malignancy, Bone Marrow Failure, Momelotinib Versus Danazol +6

Inhibiting TGF-beta signaling preserves the function of highly activated, in vitro expanded natural killer cells in AML and colon cancer models

Folashade Otegbeye, Evelyn Ojo, Stephen Moreton et al. · PLoS ONE · 2018 · 142 citations · Full text

Adoptive Nk Cells, Natural Killer Cells, Cancer Immunosurveillance +15

Membrane bound IL-21 based NK cell feeder cells drive robust expansion and metabolic activation of NK cells

Evelyn Ojo, Ashish Sharma, Ruifu Liu et al. · Scientific Reports · 2019 · 121 citations · Full text

Prophylactic Tocilizumab Prior to Anti-CD19 CAR-T Cell Therapy for Non-Hodgkin Lymphoma

Paolo F. Caimi, Gabriela Pacheco Sánchez, Ashish Sharma et al. · Frontiers in Immunology · 2021 · 109 citations · Full text

Immunology, Immune Regulation, Immunoediting +19

Multiple site place-of-care manufactured anti-CD19 CAR-T cells induce high remission rates in B-cell malignancy patients

Michael Maschan, Paolo F. Caimi, Jane Reese‐Koc et al. · Nature Communications · 2021 · 66 citations · Full text